NCT06234228

Brief Summary

This pragmatic, randomized study seeks to evaluate the applications of a novel vibrating device for reducing pediatric anxiety and distress during vascular access procedures.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,100

participants targeted

Target at P75+ for not_applicable pain

Timeline
6mo left

Started Jul 2024

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Jul 2024Nov 2026

First Submitted

Initial submission to the registry

January 22, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 31, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

July 25, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2026

Expected
Last Updated

January 7, 2026

Status Verified

January 1, 2026

Enrollment Period

1.3 years

First QC Date

January 22, 2024

Last Update Submit

January 5, 2026

Conditions

Keywords

Vascular access

Outcome Measures

Primary Outcomes (1)

  • External observation for pain and anxiety using OBSD-r scale

    OBSD-r contains 8-item scale assessing participant's affective state; Information Seeking, Crying, Screaming, Restraint, Verbal Resistance, Emotional Support, Verbal Pain and Flail.

    during vascular access procedure

Secondary Outcomes (7)

  • Faces Pain Scale-Revised for patients aged 4-11

    during vascular access procedure

  • Numerical Rating Pain Scale (NRPS) for patients aged 12-17

    during vascular access procedure

  • modified induction compliance checklist (mICC)

    during vascular access procedure

  • External observation for pain and anxiety using HRAD scale

    during vascular access procedure

  • Children's Anxiety Meter-State (CAM-S) assessment

    immediately before, immediately after vascular access procedure

  • +2 more secondary outcomes

Study Arms (3)

BHD synced with mobile game

EXPERIMENTAL

At the beginning of the vascular access procedure, the BHD will be applied 5 cm above the needle insertion site and maintained in place throughout the procedure. It delivers a constant low-frequency vibration as well as tactile feedback from the game (GF).

Behavioral: BHD synced with mobile game

BHD only

OTHER

The participant will wear the BHD 5 cm above the needle insertion site for the duration of the procedure. The BHD will deliver constant low-frequency vibration (CF).

Behavioral: Bluetooth Haptic Device (BHD)

Standard of Care

NO INTERVENTION

The participant will not receive the BHD device. Participant will receive standard of care treatment.

Interventions

The BHD will deliver constant low-frequency vibration (CF).

BHD only

The BHD delivers a constant low-frequency vibration as well as tactile feedback from the game (GF).

BHD synced with mobile game

Eligibility Criteria

Age4 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Between age 4-99
  • Will undergo a vascular access procedure
  • English speaking participant and parent or LAR

You may not qualify if:

  • Legal guardian not present to obtain consent
  • Child is unable to self-report pain or anxiety
  • Child with a significant neurological condition, or major developmental disability
  • Child with active infection of the hand or arm
  • Major surgery within the last 48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lucile Packard Childrens Hospital Stanford

Palo Alto, California, 94304, United States

Location

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Thomas Caruso, MD,PhD

    Stanford University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

January 22, 2024

First Posted

January 31, 2024

Study Start

July 25, 2024

Primary Completion

November 4, 2025

Study Completion (Estimated)

November 4, 2026

Last Updated

January 7, 2026

Record last verified: 2026-01

Locations